Form: SC TO-I

Issuer tender offer statement

December 15, 2016

Documents

Exhibit (a)(1)(g)

 

ADDENDUM

FOR WARRANT AMENDMENT PROGRAM

 

The following is a list of your outstanding warrants as of [·], which are eligible for amendment in the Warrant Amendment Program that commenced on [·];

 

Warrantholder Name:      ID:    

 

Warrant Number   Issue Date   Total Number of Shares Subject to Warrant   Do my shares of common stock issuable upon exercise of the Warrant have Registration Rights?
       
             

 

If you have questions about the above list, please direct them to Noopur Liffick, AntriaBio, Inc., 1450 Infinite Drive, Louisville, Colorado 80027, email address: investor-relations@antriabio.com.